← Eichor
Condition: Narcolepsy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Narcolepsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
Phase 2 · 18 location(s) · Takeda · NCT07633301Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06279247A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central
Phase 2/Phase 3 · 7 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07598708A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2 · 24 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07096674Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcol
NA · 2 location(s) · Hospices Civils de Lyon · NCT06484348Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05773872Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder
NA · 1 location(s) · University Hospital, Toulouse · NCT07365566A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Phase 2 · 57 location(s) · Eisai Inc. · NCT07493265Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Phase 2 · 52 location(s) · Takeda · NCT06952699A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Phase 3 · 14 location(s) · Harmony Biosciences Management, Inc. · NCT07675135A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Phase 3 · 22 location(s) · Alkermes, Inc. · NCT07455383A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy
Phase 1 · 2 location(s) · H. Lundbeck A/S · NCT07613710A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Phase 2/Phase 3 · 46 location(s) · Alkermes, Inc. · NCT06767683Extended-release Sodium Oxybate in Children
Phase 2 · 1 location(s) · Stanford University · NCT06809803Child and Adolescent Registry for Participants With Narcolepsy
Phase N/A · 25 location(s) · Jazz Pharmaceuticals · NCT04899947A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1
Phase 3 · 10 location(s) · Alkermes, Inc. · NCT07540897A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NA · 1 location(s) · University of Sydney · NCT07006233A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Phase 2/Phase 3 · 52 location(s) · Takeda · NCT05816382Mentalizating in Adults Suffering from Narcolepsy Type 1.
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT06336057Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
NA · 1 location(s) · Hospices Civils de Lyon · NCT06457945Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Phase 3 · 19 location(s) · Alkermes, Inc. · NCT07502443A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2 · 37 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT06752668A Phase 1, First-in-human Study of VX-433
Phase 1 · 1 location(s) · Vertex Pharmaceuticals Incorporated · NCT07584434Decreasing Nightmares in Adults With Narcolepsy
NA · 1 location(s) · University of Utah · NCT06383806Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
Phase N/A · 10 location(s) · Takeda · NCT07299097A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
Phase 2/Phase 3 · 1 location(s) · Takeda · NCT07646678WAKIX® (Pitolisant) Pregnancy Registry
Phase N/A · 1 location(s) · Harmony Biosciences Management, Inc. · NCT05536011Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population
Phase N/A · 2 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06292598
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.